Edwards Lifesciences Corp (NYSE: EW) is -15.01% lower on its value in year-to-date trading and has touched a low of $58.93 and a high of $95.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EW stock was last observed hovering at around $73.98 in the last trading session, with the day’s loss setting it -69.38%.
Currently trading at $4.60M, the stock is -2.99% and -1.29% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.03 million and changing 7031046% at the moment leaves the stock 3.40% off its SMA200. EW registered -0.27% loss for a year compared to 6-month gain of -0.11%. The firm has a 50-day simple moving average (SMA 50) of $74.7982 and a 200-day simple moving average (SMA200) of $71.40015.
The stock witnessed a -5.14% loss in the last 1 month and extending the period to 3 months gives it a 4.06%, and is -2.71% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.26% over the week and 0.98% over the month.
Edwards Lifesciences Corp (EW) has around 15800 employees, a market worth around $43.31B and $5.54B in sales. Current P/E ratio is 49.33 and Fwd P/E is 26.78. Profit margin for the company is 16.03%. Distance from 52-week low is 25.28% and -22.49% from its 52-week high. The company has generated returns on investments over the last 12 months (8.22%).
with sales reaching $1.49B over the same period.The EPS is expected to grow by 1.67% this year, but quarterly earnings will post 8.32% year-over-year. Quarterly sales are estimated to shrink -9.01% in year-over-year returns.
Edwards Lifesciences Corp (EW) Top Institutional Holders
1759.0 institutions hold shares in Edwards Lifesciences Corp (EW), with institutional investors hold 90.30% of the company’s shares. The shares outstanding are 586.20M, and float is at 574.70M with Short Float at 1.02%. Institutions hold 89.48% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 53.58 million shares valued at $4.95 billion. The investor’s holdings represent 8.8982% of the EW Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 50.98 million shares valued at $4.71 billion to account for 8.4663 of the shares outstanding. The other top investors are STATE STREET CORP which holds 26.01 million shares representing 4.3197% and valued at over $2.4 billion, while ALLIANCEBERNSTEIN L.P. holds 3.3784 of the shares totaling 20.34 million with a market value of $1.88 billion.
Edwards Lifesciences Corp (EW) Insider Activity
The most recent transaction is an insider sale by Wood Larry L, the company’s Global President TAVR & Surg. SEC filings show that Wood Larry L sold 8,950 shares of the company’s common stock on Jun 16 ’25 at a price of $75.23 per share for a total of $0.67 million. Following the sale, the insider now owns 0.21 million shares.
Still, SEC filings show that on May 30 ’25, Zovighian Bernard J (CEO) disposed off 16,099 shares at an average price of $77.21 for $1.24 million. The insider now directly holds 9,564 shares of Edwards Lifesciences Corp (EW).
